BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32090756)

  • 1. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder.
    Lee J; Lee KH; Kim SH; Han JY; Hong SB; Cho SC; Kim JW; Brent D
    J Affect Disord; 2020 Mar; 265():325-332. PubMed ID: 32090756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum BDNF levels before treatment predict SSRI response in depression.
    Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram.
    Ladea M; Bran M
    Psychiatr Danub; 2013 Jun; 25(2):128-32. PubMed ID: 23793276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
    Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
    J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotrophic factors in depression in response to treatment.
    Buttenschøn HN; Foldager L; Elfving B; Poulsen PH; Uher R; Mors O
    J Affect Disord; 2015 Sep; 183():287-94. PubMed ID: 26047306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study.
    Ran LY; Liu XY; Wang W; Tao WQ; Xiang JJ; Zeng Q; Kong YT; Zhang CY; Liao J; Qiu HT; Kuang L
    J Affect Disord; 2024 Apr; 350():102-109. PubMed ID: 38199422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report.
    Martocchia A; Curto M; Scaccianoce S; Comite F; Xenos D; Nasca C; Falaschi GM; Ferracuti S; Girardi P; Nicoletti F; Falaschi P
    Aging Clin Exp Res; 2014 Aug; 26(4):461-4. PubMed ID: 24435333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram.
    Sagud M; Nikolac Perkovic M; Dvojkovic A; Jaksic N; Vuksan-Cusa B; Zivkovic M; Kusevic Z; Mihaljevic-Peles A; Pivac N
    Psychopharmacology (Berl); 2021 Jun; 238(6):1575-1584. PubMed ID: 33560444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Antidepressant Treatment on Symptom Measures of Attention in Adolescents with Depression: A Preliminary Open-Label Study.
    Choi CH; Lee J; Lee KH; Hong SB; Kim SH; Han JY; Kim JW; Cho SC; Kim JW
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):288-293. PubMed ID: 33417814
    [No Abstract]   [Full Text] [Related]  

  • 13. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents.
    Lee KH; Shin J; Lee J; Yoo JH; Kim JW; Brent DA
    JAMA Netw Open; 2023 Aug; 6(8):e2327331. PubMed ID: 37540512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual function improves as depressive symptoms decrease during treatment with escitalopram: results of a naturalistic study of patients with major depressive disorder.
    Weber S; Frokjaer VG; Armand S; Nielsen JH; Knudsen GM; Joergensen MB; Stenbaek DS; Giraldi A
    J Sex Med; 2023 Feb; 20(2):161-169. PubMed ID: 36763929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
    Shimizu E; Hashimoto K; Okamura N; Koike K; Komatsu N; Kumakiri C; Nakazato M; Watanabe H; Shinoda N; Okada S; Iyo M
    Biol Psychiatry; 2003 Jul; 54(1):70-5. PubMed ID: 12842310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF methylation and depressive disorder in acute coronary syndrome: The K-DEPACS and EsDEPACS studies.
    Kim JM; Stewart R; Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS
    Psychoneuroendocrinology; 2015 Dec; 62():159-65. PubMed ID: 26313133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
    Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
    J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.